Former Cancer Drug Very Promising for Graves’ Ophthalmopathy

by Medscape • 2017/05/04 • 0 Comments

Originally developed as a cancer drug, teprotumumab shows "unheralded" efficacy at relieving symptoms of thyroid eye disease, one investigator said.
Medscape Medical News

Full Story →

← Global Intraocular Lens Market to Grow at a CAGR of 7% by 2022: Rise in Initiatives Taken by Government to Eliminate Avoidable Blindness – Research and Markets

Teprotumumab more effective than placebo in treating active ophthalmopathy →

Post navigation